10/24/2013

Following Supreme Court rulings that blocked as many as 157 clinical trials in 2012, India's Ministry of Health and the Central Drugs Standard Control Organization have effectively stopped reviewing and approving any of the more than 150 pending applications, according to industry officials. "There is certainly an impact on the business because the normal work has suffered and the Indian industry is losing opportunity," said Suneela Thatte, president of the Indian Society for Clinical Research.

Related Summaries